Statin choice for lipid6lowering therapy: clinical pharmacology and evidence-based medicine position
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
The features of various statins’ use are analysed taking into consideration their clinical and pharmacological parameters. The present evidence base on atorvastatin and rosuvastatin is emphasised. The author compares various statins in regard to their potential in atherosclerotic plaque reduction, according to intravascular ultrasound data. Substantial benefits of lipid-lowering monotherapy by “new” vs “old” statins are demonstrated.
References
1. Jones P, Kafonek S, Laurora I, et al. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia (The Curves study). Am J Cardiol 1998; 81: 582-7.
2. Nawrocki JW, Weiss SR, Davidson MH, et al. Reduction of LDL cholesterol by 25 % to 60 % in patients with primary hypercholesterolemia by atorvastatin a new HMS-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol 1995; 15: 678-82.
3. Smith DG, Leslie SJ, Szucs TD, et al. Cost of treating to a modified European Atherosclerosis Society LDL6C target. Comparison of atorvastatin with fluvastatin, pravastatin and simvastatin. (Treatto-Target Study). Clin Drug Invest 1999; 17: 185-93.
4. Athyros VG, Papageorgiou AA, Mercouris BR, et al. Treatment with atorvastatin to the National cholesterol educational program goal versus “usual” care in secondary coronary heart disease prevention: The GREek Atorvastatin and Coronary-heartdisease Evaluation Study (GREACE). Cur Med Res Opin 2002; 18: 220-8.
5. Nissen S, Tuzcu M, Schoenhagen P. Effect of Intensive Compared With Moderate Lipid6Lowering Therapy on Progression of Coronary Atherosclerosis. JAMA 2004; 291: 1071-80.
6. Okazaki S, Yokoyama T, Miyauchi K Early Statin Treatment in Patients With Acute Coronary Syndrome. Demonstration of the Beneficial Effect on Atherosclerotic Lesions by Serial Volumetric Intravascular Ultrasound Analysis During Half a Year After Coronary Event: The ESTABLISH Study. Circulation 2004; 110: 1061-8.
7. Nissen S, Nicholls S, Sipahi I. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. The ASTERIOD trial. JAMA 2006; 295: 1556-65.
8. Newman BC, Palmary G, Sielbershats H, Szarek M. Safety of atorvastatin derived from analysis of 44 completed trail in 9,416 patients. Am J Cardiol 2003; 92: 670-6.
Review
For citations:
Nedogoda S.V. Statin choice for lipid6lowering therapy: clinical pharmacology and evidence-based medicine position. Cardiovascular Therapy and Prevention. 2008;7(1):112-115. (In Russ.)
Views:
1800
ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)
ISSN 2619-0125 (Online)
Email this article 
